The document describes automating the Illumina TruSeq DNA PCR-Free Sample Preparation Kit using the Beckman Coulter Biomek FXP automated liquid handler. The automation allows generating up to 96 individually barcoded DNA libraries in approximately 5 hours without PCR amplification. The method was tested by constructing libraries from human genomic DNA, which were then sequenced and shown to have the expected size distribution and quality.
Maximizing PCR and RT-PCR Success - Download the BrochureQIAGEN
The invention of the polymerase chain reaction (PCR) by K. Mullis and coworkers in 1985 revolutionized molecular biology and molecular medicine. Major research areas, such as biomarker discovery, gene regulation and cancer research are challenging today’s PCR technologies with more demanding requirements. These include the need for increased throughput while reducing costs, higher assay sensitivity and reliable data normalization. Assay development and evaluation, reproducibility of data and time to result are still major problems encountered by researchers.
Meeting today’s challenges in PCR requires advances in all methods of the workflow that starts with sample collection, sample stabilization, and nucleic acid purification, and ends with amplification and detection. The following pages focus on the importance of amplification in meeting these challenges.
Maximizing PCR and RT-PCR Success - Download the BrochureQIAGEN
The invention of the polymerase chain reaction (PCR) by K. Mullis and coworkers in 1985 revolutionized molecular biology and molecular medicine. Major research areas, such as biomarker discovery, gene regulation and cancer research are challenging today’s PCR technologies with more demanding requirements. These include the need for increased throughput while reducing costs, higher assay sensitivity and reliable data normalization. Assay development and evaluation, reproducibility of data and time to result are still major problems encountered by researchers.
Meeting today’s challenges in PCR requires advances in all methods of the workflow that starts with sample collection, sample stabilization, and nucleic acid purification, and ends with amplification and detection. The following pages focus on the importance of amplification in meeting these challenges.
Multicopy reference assay (MRef) — a superior normalizer of sample input in D...QIAGEN
Copy number variations (CNVs) and alterations (CNAs) are a source of genetic diversity in humans and are often pathogenic. Numerous CNVs and CNAs are being identified with various genome analysis platforms, including array comparative genomic hybridization (aCGH), single nucleotide polymorphism (SNP) genotyping platforms, and next-generation sequencing. Independent verification of copy number changes is a critical step. Quantitative real-time PCR (qPCR) is a classic method to verify microarray copy number findings. Traditional copy number assays that use qPCR typically rely on a putative single-copy gene reference assay (e.g., RNase P or TERT) to normalize the DNA input for downstream ΔΔCT-based copy number calculation for comparison to a reference genome. When applied to cancer samples, these single-copy reference assays may no longer be a reliable indicator of DNA input due to the presence of complex chromosome composition (both in chromosome number and structure). To meet the need for an accurate DNA input normalizer, especially for heterogeneous tumor samples, QIAGEN developed a multicopy reference (MRef) assay for real-time PCR copy number analysis. This assay, in conjunction with QIAGEN’s greater than 10 million genomewide copy number assays and pathway- and disease-focused copy number PCR arrays (Figure 1), provides a successful solution for copy number analysis. This article will address the assay design considerations, development, and performance of this multicopy reference (MRef) assay.
Purification of total RNA from peripheral blood mononuclear cells - Download ...QIAGEN
Peripheral blood is often used for in vitro studies of the human immune system or immune responses, such as inflammation. An important part of the human immune system is represented by the peripheral blood mononuclear cells (PBMC). PBMC are blood cells characterized by a round nucleus and consist mainly of lymphocytes (T cells, B cells, and NK cells), macrophages and dendritic cells. Here, we describe the analysis of lipopolysaccharide-induced transcriptional response of isolated PBMC from whole blood using the RNeasy® Mini Kit or RNeasy Micro Kit, RT2 First Strand Kit, RT2 SYBR® Green ROX™ qPCR Mastermix, and RT2 Profiler PCR Arrays.
Automated DNA extraction from FFPE tissue using a xylene free deparaffinizati...QIAGEN
Formalin-fixed paraffin-embedded (FFPE) tissue samples are routinely used for immunohistochemistry and molecular analysis in cancer research. However, many methods for DNA extraction from FFPE tissue sections are manual procedures that are not standardized, time consuming and often involve the use of hazardous materials like xylene. Recently we introduced an automated solution for the DNA extraction from FFPE tissue using the QIAsymphony SP instrument in combination with the QIAsymphony DNA Mini kit.
Extending miRQC’s dynamic range: amplifying the view of Limiting RNA samples ...QIAGEN
The original microRNA quality control (miRQC) study provided an in-depth analysis of commercially available microRNA (miRNA) quantification platforms. Specifically, twelve different
microarray, real-time PCR and small RNA sequencing platforms were assessed for reproducibility, sensitivity, accuracy, specificity and concordance of differential expression using a variety of sample types. Overall, each platform exhibited specific strengths and weaknesses, leading to the
final suggestion that a platform should be chosen on the basis of the experimental setting and the specific research questions. With this suggestion in mind, and the fact that liquid miRNA biopsies are an area of intense interest, we sought to expand the original miRQC study. For our “miRQC extension,” we benchmarked the QIAGEN miScript® PCR System with and without preamplification, and included a specific focus on routinely used biofluids. Concurrently, we benchmarked the miScript PCR System against another SYBR® Green miRNA detection platform. Overall, QIAGEN miScript demonstrated strong reproducibility and accuracy as well as superior detection rate and sensitivity in biofluids. Collectively, QIAGEN miScript provides the leading solution for novel miRNA discoveries.
Automated DNA purification from diverse Microbiome samples using dedicated Mi...QIAGEN
This application note demonstrates the automation of QIAGEN’s new line of DNA sample prep kits for the microbiome. The microbiome of samples as diverse as soil, water and stool was purified using dedicated QIAcube compatible kits. Automation on the QIAcube enabled efficient and reliable use of these samples for sensitive downstream applications such as qPCR and NGS. In addition, the CLC Microbial Genomics Module was successfully employed for metagenome sequencing and identification of microbial composition and diversity.
QIAcube® RNA isolation from stool samples using the RNeasy® PowerMicrobiome® ...QIAGEN
This application note demonstrates that RNA is extracted efficiently from stool samples using the RNeasy PowerMicrobiome Kit and the QIAcube system. Furthermore, the RNA isolated with the RNeasy PowerMicrobiome Kit and the QIAcube system is compatible with downstream applications.
Sequential Automation of RNA and DNA preps on the same QIAcube instrumentQIAGEN
Automation of QIAGEN spin-column kits on the QIAcube saves valuable time and ensures standardized results. Since the same QIAcube may be used by multiple researchers for different applications, cross-contamination between samples and preparation technologies must be avoided (e.g., when nucleases are used). The unique instrument design and features minimize contamination between sequential preps, allowing both RNA and DNA preps to be performed on the same instrument. To show the process safety and robustness, we performed alternating automated RNA preps (requiring a DNase step) and DNA plasmid preps (requiring an RNase step). The preps were sequentially performed on the same QIAcube instrument using the RNeasy® Mini Kit and the QIAprep® Spin Miniprep Kit, respectively.
Independently, we performed a series of manually processed preps to compare with the automated preps. RNA and DNA quality and yields were similar between the two methods, showing the absence of carryover of nucleases.
Technical Guide to Qiagen PCR Arrays - Download the GuideQIAGEN
Total RNA discovery with RT2 and miScript PCR Arrays : Explore the RNA universe - Whatever your destination within the RNA universe, QIAGEN will help you get there. The miRNeasy kits deliver pure, high-quality total RNA from a broad range of samples. The RT2 and miScript PCR arrays are a complete solution both for focused analysis of gene and microRNA expression and for validation of microarray and RNA sequencing experiments. Together with the powerful analytics tools of GeneGlobe® and QIAGEN Ingenuity® Pathway Analysis, these products give you a smooth path from your sample to high-quality results.
Optimal RNAlater® incubation and removal conditions prior to isolation of tot...QIAGEN
RNA is highly sensitive to degradation. Handling methods and prolonged storage of cells can greatly affect the quality of the RNA that can be later isolated. Contamination with RNases is the most significant problem, especially as they are so ubiquitous in the environment. They can degrade RNA to the point where results of downstream analyses become meaningless.
Submerging cells in RNAlater, an RNA stabilization reagent, helps to stabilize the RNA within the cells and prevent degradation, supporting accurate downstream gene expression analyses. However, to avoid any interference from any RNAlater components in isolation and analyses, cells must be pelleted and the reagent must be removed. The separation of cells from excess RNAlater via centrifugation is impeded due to the higher density of the reagent compared to standard culture medium. This means it requires higher centrifugal forces, which might damage cells due to increased shearing forces, leading to reduced RNA yield. The aim of this study was to establish the optimal conditions for the recovery of cells from RNAlater after RNA stabilization for maximum RNA yield and integrity.
Cancer is a disease characterized by uncontrolled cell growth and proliferation. Recent advances in molecular medicine and cancer biology have changed the way research clinicians evaluate and consider treatment. Selected tumor biomarkers have been utilized as targets for drug therapy leading to better more effective treatment. Gene expression profiling has been used for identifying new biomarkers for tumor classification and driving decision making for better patient outcome in different tumor types. DNA microarrays have become a key method to acquire a comparative snapshot of the gene expression profile from test samples in a high throughput manner. Quantitative PCR and newer sequencing techniques are popular research alternatives offering highly accurate gene expression measurements, but with limitations due to cost, complex instrumentation and analysis needs. RNA extracted from formalin fixed paraffin embedded tissue (FFPE) creates considerable additional challenges in acquiring accurate gene expression measurements due to the highly fragmented and compromised integrity of FFPE RNA due to the fixation process.
Single-cell microRNA expression profiling is a challenging workflow. From cell lysis, reverse transcription, preamplificatin to real-time PCR, every step involves technical pitfalls. Therefore it is critical to have a robust system that facilitates universal cDNA synthesis and universal amplification of all miRNAs in one workflow without introducing bias. Here we present a new poster – introducing a robust real-time PCR workflow and protocol for profiling miRNA expression from a single cell and how we analyze the single cells by using the free data analysis software.
Learn about the power of LNA (Locked Nucleic Acid) technology and QIAGEN's LNA enhanced product portfolio for RNA and DNA research. Download the slide deck!
Rapid extraction of high yield, high quality DNA from tissue samples - Downlo...QIAGEN
Genetic and genomic analysis from tissue samples requires the extraction of high quality DNA. Mechanical disruption methods such as bead milling provide high yield from tissue samples, but cause damage to the nucleic acids. Purely enzymatic methods such as proteinase K digestion can extract nucleic acid without damage, but require long incubation times, often proceeding overnight, and without approaching the yields achieved by mechanical disruption techniques. Thus a method is needed which can provide a rapid extraction of high yield, high quality DNA from tissue samples. See the new method.
Construction of The ScFv Library: The amplified VH and linker-VL genes were gel-purified on agarose, the scFv assembly and expression vector were digested and ligated to gain scFv library.
Multicopy reference assay (MRef) — a superior normalizer of sample input in D...QIAGEN
Copy number variations (CNVs) and alterations (CNAs) are a source of genetic diversity in humans and are often pathogenic. Numerous CNVs and CNAs are being identified with various genome analysis platforms, including array comparative genomic hybridization (aCGH), single nucleotide polymorphism (SNP) genotyping platforms, and next-generation sequencing. Independent verification of copy number changes is a critical step. Quantitative real-time PCR (qPCR) is a classic method to verify microarray copy number findings. Traditional copy number assays that use qPCR typically rely on a putative single-copy gene reference assay (e.g., RNase P or TERT) to normalize the DNA input for downstream ΔΔCT-based copy number calculation for comparison to a reference genome. When applied to cancer samples, these single-copy reference assays may no longer be a reliable indicator of DNA input due to the presence of complex chromosome composition (both in chromosome number and structure). To meet the need for an accurate DNA input normalizer, especially for heterogeneous tumor samples, QIAGEN developed a multicopy reference (MRef) assay for real-time PCR copy number analysis. This assay, in conjunction with QIAGEN’s greater than 10 million genomewide copy number assays and pathway- and disease-focused copy number PCR arrays (Figure 1), provides a successful solution for copy number analysis. This article will address the assay design considerations, development, and performance of this multicopy reference (MRef) assay.
Purification of total RNA from peripheral blood mononuclear cells - Download ...QIAGEN
Peripheral blood is often used for in vitro studies of the human immune system or immune responses, such as inflammation. An important part of the human immune system is represented by the peripheral blood mononuclear cells (PBMC). PBMC are blood cells characterized by a round nucleus and consist mainly of lymphocytes (T cells, B cells, and NK cells), macrophages and dendritic cells. Here, we describe the analysis of lipopolysaccharide-induced transcriptional response of isolated PBMC from whole blood using the RNeasy® Mini Kit or RNeasy Micro Kit, RT2 First Strand Kit, RT2 SYBR® Green ROX™ qPCR Mastermix, and RT2 Profiler PCR Arrays.
Automated DNA extraction from FFPE tissue using a xylene free deparaffinizati...QIAGEN
Formalin-fixed paraffin-embedded (FFPE) tissue samples are routinely used for immunohistochemistry and molecular analysis in cancer research. However, many methods for DNA extraction from FFPE tissue sections are manual procedures that are not standardized, time consuming and often involve the use of hazardous materials like xylene. Recently we introduced an automated solution for the DNA extraction from FFPE tissue using the QIAsymphony SP instrument in combination with the QIAsymphony DNA Mini kit.
Extending miRQC’s dynamic range: amplifying the view of Limiting RNA samples ...QIAGEN
The original microRNA quality control (miRQC) study provided an in-depth analysis of commercially available microRNA (miRNA) quantification platforms. Specifically, twelve different
microarray, real-time PCR and small RNA sequencing platforms were assessed for reproducibility, sensitivity, accuracy, specificity and concordance of differential expression using a variety of sample types. Overall, each platform exhibited specific strengths and weaknesses, leading to the
final suggestion that a platform should be chosen on the basis of the experimental setting and the specific research questions. With this suggestion in mind, and the fact that liquid miRNA biopsies are an area of intense interest, we sought to expand the original miRQC study. For our “miRQC extension,” we benchmarked the QIAGEN miScript® PCR System with and without preamplification, and included a specific focus on routinely used biofluids. Concurrently, we benchmarked the miScript PCR System against another SYBR® Green miRNA detection platform. Overall, QIAGEN miScript demonstrated strong reproducibility and accuracy as well as superior detection rate and sensitivity in biofluids. Collectively, QIAGEN miScript provides the leading solution for novel miRNA discoveries.
Automated DNA purification from diverse Microbiome samples using dedicated Mi...QIAGEN
This application note demonstrates the automation of QIAGEN’s new line of DNA sample prep kits for the microbiome. The microbiome of samples as diverse as soil, water and stool was purified using dedicated QIAcube compatible kits. Automation on the QIAcube enabled efficient and reliable use of these samples for sensitive downstream applications such as qPCR and NGS. In addition, the CLC Microbial Genomics Module was successfully employed for metagenome sequencing and identification of microbial composition and diversity.
QIAcube® RNA isolation from stool samples using the RNeasy® PowerMicrobiome® ...QIAGEN
This application note demonstrates that RNA is extracted efficiently from stool samples using the RNeasy PowerMicrobiome Kit and the QIAcube system. Furthermore, the RNA isolated with the RNeasy PowerMicrobiome Kit and the QIAcube system is compatible with downstream applications.
Sequential Automation of RNA and DNA preps on the same QIAcube instrumentQIAGEN
Automation of QIAGEN spin-column kits on the QIAcube saves valuable time and ensures standardized results. Since the same QIAcube may be used by multiple researchers for different applications, cross-contamination between samples and preparation technologies must be avoided (e.g., when nucleases are used). The unique instrument design and features minimize contamination between sequential preps, allowing both RNA and DNA preps to be performed on the same instrument. To show the process safety and robustness, we performed alternating automated RNA preps (requiring a DNase step) and DNA plasmid preps (requiring an RNase step). The preps were sequentially performed on the same QIAcube instrument using the RNeasy® Mini Kit and the QIAprep® Spin Miniprep Kit, respectively.
Independently, we performed a series of manually processed preps to compare with the automated preps. RNA and DNA quality and yields were similar between the two methods, showing the absence of carryover of nucleases.
Technical Guide to Qiagen PCR Arrays - Download the GuideQIAGEN
Total RNA discovery with RT2 and miScript PCR Arrays : Explore the RNA universe - Whatever your destination within the RNA universe, QIAGEN will help you get there. The miRNeasy kits deliver pure, high-quality total RNA from a broad range of samples. The RT2 and miScript PCR arrays are a complete solution both for focused analysis of gene and microRNA expression and for validation of microarray and RNA sequencing experiments. Together with the powerful analytics tools of GeneGlobe® and QIAGEN Ingenuity® Pathway Analysis, these products give you a smooth path from your sample to high-quality results.
Optimal RNAlater® incubation and removal conditions prior to isolation of tot...QIAGEN
RNA is highly sensitive to degradation. Handling methods and prolonged storage of cells can greatly affect the quality of the RNA that can be later isolated. Contamination with RNases is the most significant problem, especially as they are so ubiquitous in the environment. They can degrade RNA to the point where results of downstream analyses become meaningless.
Submerging cells in RNAlater, an RNA stabilization reagent, helps to stabilize the RNA within the cells and prevent degradation, supporting accurate downstream gene expression analyses. However, to avoid any interference from any RNAlater components in isolation and analyses, cells must be pelleted and the reagent must be removed. The separation of cells from excess RNAlater via centrifugation is impeded due to the higher density of the reagent compared to standard culture medium. This means it requires higher centrifugal forces, which might damage cells due to increased shearing forces, leading to reduced RNA yield. The aim of this study was to establish the optimal conditions for the recovery of cells from RNAlater after RNA stabilization for maximum RNA yield and integrity.
Cancer is a disease characterized by uncontrolled cell growth and proliferation. Recent advances in molecular medicine and cancer biology have changed the way research clinicians evaluate and consider treatment. Selected tumor biomarkers have been utilized as targets for drug therapy leading to better more effective treatment. Gene expression profiling has been used for identifying new biomarkers for tumor classification and driving decision making for better patient outcome in different tumor types. DNA microarrays have become a key method to acquire a comparative snapshot of the gene expression profile from test samples in a high throughput manner. Quantitative PCR and newer sequencing techniques are popular research alternatives offering highly accurate gene expression measurements, but with limitations due to cost, complex instrumentation and analysis needs. RNA extracted from formalin fixed paraffin embedded tissue (FFPE) creates considerable additional challenges in acquiring accurate gene expression measurements due to the highly fragmented and compromised integrity of FFPE RNA due to the fixation process.
Single-cell microRNA expression profiling is a challenging workflow. From cell lysis, reverse transcription, preamplificatin to real-time PCR, every step involves technical pitfalls. Therefore it is critical to have a robust system that facilitates universal cDNA synthesis and universal amplification of all miRNAs in one workflow without introducing bias. Here we present a new poster – introducing a robust real-time PCR workflow and protocol for profiling miRNA expression from a single cell and how we analyze the single cells by using the free data analysis software.
Learn about the power of LNA (Locked Nucleic Acid) technology and QIAGEN's LNA enhanced product portfolio for RNA and DNA research. Download the slide deck!
Rapid extraction of high yield, high quality DNA from tissue samples - Downlo...QIAGEN
Genetic and genomic analysis from tissue samples requires the extraction of high quality DNA. Mechanical disruption methods such as bead milling provide high yield from tissue samples, but cause damage to the nucleic acids. Purely enzymatic methods such as proteinase K digestion can extract nucleic acid without damage, but require long incubation times, often proceeding overnight, and without approaching the yields achieved by mechanical disruption techniques. Thus a method is needed which can provide a rapid extraction of high yield, high quality DNA from tissue samples. See the new method.
Construction of The ScFv Library: The amplified VH and linker-VL genes were gel-purified on agarose, the scFv assembly and expression vector were digested and ligated to gain scFv library.
Next Gen Sequencing Technologies OverviewPatrick Merel
A presentation of the major nextgen sequencing technologies. Price indications were valid 1st quarter of 2009. Mac keynote file, half french half english. Hope this can help.
Sample preparation automation through emerging microfluidic technologies 2015...Yole Developpement
Report’s key features
Overview of current bottlenecks in sample preparation
Specific focus on sample preparation for Next-Generation Sequencing (NGS), Single-Cell and Molecular Diagnostics, including point-of-care and trace analysis
Review of reference technologies vs. emerging microfluidic technologies
2015-2020 forecasts for microfluidics for sample preparation in Single-Cell and NGS markets
Market trend analysis
Supply chain analysis and main player map for each application
Business cases on NGS sample prep: microfluidic automation vs. reference solutions, ROI analysis
Application Note: A Simple One-Step Library Prep Method To Enable AmpliSeq Pa...QIAGEN
Targeted amplicon sequencing is a cost-effective, convenient and rapid method for variant detection. This application note outlines a straightforward workflow that uses the QIAseq 1-Step Amplicon Library kit to verify AmpliSeq targeted sequencing assays on the Illumina sequencing instruments. By combining end-repair and ligation, the QIAseq 1-Step Amplicon Library Kit offers a fast and efficient 30-minute procedure for the preparation of high-quality, artifact-free Illumina libraries from any PCR amplicons, including AmpliSeq Panels.
Circulating cell free DNA is a potential tumor marker in a non-invasive blood test for the treatment and evaluation of cancer and recurrence monitoring. As circulating tumor DNA is often present at low frequencies within circulating cell free DNA, targeted sequencing on the Ion Torrent™ platform is an optimal tool or mutation detection with very little sample input required. Here, we demonstrate a complete workflow from isolation through molecular characterization of circulating tumor DNA. We have optimized a protocol using magnetic beads to isolate circulating cell free DNA. This protocol is easily automated to process up to 192 samples a day. It is also easily scalable for any input volume and can elute in volumes down to 15 μL resulting in no loss of low frequency alleles. We demonstrate comparable performance between this bead based isolation and column based isolation. We have completed molecular characterization of circulating cell free DNA using the multiplexing capabilities of AmpliSeq™ and the Ion PGM™. With the Ion AmpliSeq™ Cancer Hotspot Panel v2, we performed targeted sequencing of 50 genes of interest, covering 2800 COSMIC mutations. We demonstrate good reproducibility of amplicon representation as well as allelic frequencies. Through saturation studies and subsampling, we have determined the limit of detection of hotspots circulating cell free DNA on the Ion PGM™ to be below 1%. We further demonstrate proof of principle of this workflow on circulating cell free DNA and matched FFPE samples. Our results verify the accuracy and ease of our workflow. This protocol, from isolation through targeted sequencing, will not only result in a simple sample preparation for circulating cell free DNA but also facilitate rapid mutation detection to advance cancer research.
High data quality and accuracy are recognized characteristics of Sanger re-sequencing projects and are primary reasons that next generation sequencing projects compliment their results by capillary electrophoresis data validation. We have developed an on-line tool called Primer Designer™ to streamline the NGS-to-Sanger sequencing workflow by taking the laborious task of PCR primer design out of the hands of the researcher by providing pre-designed assays for the human exome. The primer design tool has been created to enable scientists using next generation sequencing to quickly confirm variants discovered in their work by providing the means to quickly search, order and receive suitable pre-designed PCR primers for Sanger sequencing. Using the Primer Designer™ tool to design M13-tailed and non-tailed PCR primers for Sanger sequencing we will demonstrate validation of 28-variants across 24-amplicons and 19-genes using the BDD, BDTv1.1 and BDTv3.1 sequencing chemistries on the 3500xl Genetic Analyzer capillary electrophoresis platform.
Diese Broschüre beschreibt die Einzigartigkeit dieses innovativen und perfekt designten qPCR Realtime-Cyclers. Welcher qPCR-Cycler bietet sonst noch 120 optische Kanäle, die gleichzeitige Abarbeitung von TaqMan und Hybridisierungssonden, 7plex-Analysen, und das Alles bei einer thermischen Uniformität von 0,05°C? Sprechen Sie uns an unter info@labortechnik.com oder besuchen Sie uns auf unserer Website https://www.labortechnik.com/de .
High-throughput processing to maximize genomic analysis through simultaneous ...Thermo Fisher Scientific
As personalized cancer care evolves, the patient’s nucleic acid becomes ever so important to provide valuable information regarding their genetic makeup and disease state. Common sample types for these analyses include biopsies, which can be very limited in material making the downstream measurement of more than one analyte rather difficult. Obtaining another biopsy, using a different section or splitting the sample can be problematic because of tumor heterogeneity. Even adjacent areas of the same tumor tissue can result in different RNA/DNA profiles so the ability to isolate multiple analytes from the same sample offer a number of benefits, which include preserving samples and data consistency eliminating any sample to sample variation. As more tests are developed to simultaneously monitor genetic alterations, there is a strong need to efficiently isolate both DNA and RNA from the same starting sample in a format compatible with high-throughput processing.
A product launch power point for NGS sequencing qPCR Quantification kit. A unique kit directly measures library concentration, providing the fast and reliable solution for cluster density estimation for NGS.
Achieve Complete Coverage of the SARS-CoV-2 GenomeCamille Cappello
Utilize multiple overlapping amplicons in a single tube, using a rapid, 2-hour workflow to prepare ready-to-sequence libraries. The PCR1+PCR2 workflow generates robust libraries even from low input quantities of DNA that may be subsequently quantified and normalized with conventional methods such as Qubit® or Agilent Bioanalyzer, or optionally using the included Swift Normalase reagents.
Provides coverage of >99% of the SARS-CoV-2 genome from limited viral titers
Similar to Illumina TruSeq DNA PCR-Free_Biomek FXP Automated Workstation (20)
Achieve Complete Coverage of the SARS-CoV-2 Genome
Illumina TruSeq DNA PCR-Free_Biomek FXP Automated Workstation
1. Automation of the Illumina®TruSeq® DNA PCR-Free Sample
Preparation Kit on the Biomek FXP
Automated Liquid Handler
Abstract
In this technical note, we describe the automation of
the Illumina TruSeq DNA PCR-Free Sample Preparation
Kit on the Beckman Coulter BiomekFXP
Dual-Arm
System, Multichannel Pipettor and Span-8 Pipettor
automated liquid handler (Biomek FXP
). The Illumina
PCR-Free automated method is designed to work with
the Illumina TruSeq DNA PCR-Free Sample Preparation
Kit (FC-121-3001, FC-121-3002 or FC-121-3003), and
allows the user to create up to 96 individually barcoded
DNA libraries per method run—using either the LT
or HT versions of the Illumina TruSeq DNA PCR-Free
Kit. As the name of the kit implies, the libraries generated
with this method do not undergo PCR amplification,
which reduces nucleic acid composition bias and
eliminates the risk of artifacts introduced via PCR.
The method provides users with the option to utilize
either off-deck incubations using an external thermocycler,
or to perform incubations on-deck with a Biometra
T-Robot thermocycler integrated to the Biomek FXP
liquid handler. The method employs individual Span-8
probes to deliver enzyme and reagent transfers while
DNA cleanup, wash, and elution transfers are performed
using the multichannel 96 pipetting head. A static Peltier
unit ensures that enzyme master mixes are kept cool
during the course of the method. The Illumina PCR-Free
automated method can generate up to 96 Illumina TruSeq
DNA PCR-Free libraries in approximately 5 hours.
The method also incorporates all recommended stop
points described in the Illumina TruSeq DNA PCR-
Free protocol to allow users the maximum amount of
flexibility in planning their experiments.
Protocol
This automated method utilizes the Biomek FXP
automated
liquid handler in conjunction with the Illumina TruSeq DNA
PCR-Free Sample Preparation Kit protocol (15036187 Rev. B).
Automation consumables, instrument configuration, and
other details can be found at the end of this document. An
overview of the method workflow can be seen in Figure 1.
Fig. 1. Automated Illumina TruSeq DNA PCR-Free workflow. Blue
indicates sample inputs; red indicates stop points; and grey indicates
method steps.
50µl Covaris
sheared gDNA
Purification of
Fragmented gDNA
End Repair
Reaction
Post Ligation
Cleanups
Proceed to Library
Characterization
Optional
Method
Stop
Point
End Repair
Cleanup and Size
Selection
Atailing Reaction
Adaptor Ligation
Biomek FXP
Workstation
2. The automated Illumina TruSeq DNA PCR-Free method
utilizes an HTML-driven User Interface (UI) that allows
the user to customize his workflow by offering a number
of different options. Among the major options offered
by the UI, the user may select: (1) any number of samples
between 1 and 96 to process; (2) whether to use on-
deck or off-deck incubations; (3) which size selection
option (350 bp inserts or 550 bp inserts) to be used in
the library construction procedure; and (4) how much
of the library construction workflow to run. Several
options are provided around the addition of the TruSeq
adapters to the deck, including an optional pause step in
the method to add the TruSeq adapter labware to the
deck and the ability to perform custom TruSeq adapter
transfers based on a user-supplied CSV-formatted file.
Additionally, the user can specify the type of labware
containing the TruSeq adapters including tubes, any number
of 96-well PCR plate types, or the Illumina DAP plate
supplied with the HT version of the Illumina TruSeq DNA
PCR-Free Sample Preparation Kit. Finally, the UI allows
the user to enable event logging—which records major
events such as master mix additions—in a LIMS accessible
file. An image of the UI is presented in Figure 2.
Fig. 2. Automated Illumina PCR-Free user interface.
Fig. 3. Automated Illumina PCR-Free reagent calculator.
In addition to the user interface, the automated Illumina
PCR-Free method provides the user with an HTML-
driven reagent calculator that provides the user with the
final volumes of all of the reagents and master mixes
required on the deck. It also gives instructions on how
to generate the various master mixes based upon the
number of samples to be processed and the amount of
the workflow that the user wishes to pursue. An image
of the reagent calculator is shown in Figure 3.
Experimental Design and Results
Eight 1 µg aliquots of Human Female Reference Genomic
DNA (Promega P/N G1521) were sheared using a
Covaris®
S220 (Covaris) utilizing the settings outlined
in the Illumina TruSeq DNA PCR-Free Library Preparation
Kit protocol (15036187 Rev. B) for a 350 bp insert size.
Following shearing, the input DNA was pooled into a
single tube, vortexed, and assayed on the Agilent 2200
TapeStation (Agilent Technologies) using D1000 High-
Sensitivity ScreenTape (P/N 5067-5584) to ensure the
targeted insert size of 350 bp was reached (Figure 4).
3. Fig. 4. Human Reference gDNA following shearing on the Covaris S220.
Fig. 5. Illumina TruSeq DNA PCR-Free libraries constructed with
the Biomek FX.P
Fig. 6. Sequence-ready library yields as determined by qPCR.
Mean library yield was 9.3 nM.
Fig. 7. Bowtie 2 mapping results for Illumina TruSeq DNA
PCR-Free libraries.
Following library construction, the quality and size
distribution of the libraries was analyzed using the
Agilent DNA High Sensitivity kit (5067-4626) and Agilent
2100 Bioanalyzer. Representative Bioanalyzer 2100
results are shown in Figure 5. The library concentrations
were measured using KAPA SYBR Fast Universal 2X
qPCR Master Mix library quantification kits (P/N KK4824,
Kapa Biosystems), and are summarized in Figure 6.
Seven Illumina TruSeq DNA PCR-Free libraries were
sequenced on an Illumina MiSeq®
2x101 cycle paired
end run, which generated over 9 million pass filter reads
from the Illumina TruSeq DNA PCR-Free libraries.
The reads were then mapped to the human reference
genome (hg19) using Bowtie 2 mapping software
implemented on the public instance of Galaxy
(usegalaxy.org) using default parameters. Mapping metrics
are presented in Figure 7. Following mapping, insert size
distributions were calculated for each of the 7 libraries
using the Picard Insertion Size Metrics tool, also installed
on the public instance of Galaxy. Median size insert
values for the 7 libraries were 386±6 bp. Standard
deviations for the 7 libraries were 86±2 bp. A representative
size insert distribution is presented in Figure 8.
0 Times
0.0% 10.0% 20.0% 30.0% 40.0% 50.0% 60.0% 70.0% 80.0% 90.0% 100.0%
1
2
3
4
5
6
7
Exactly 1Time
More Than 1 Time
IlluminaTruSeqDNAPCR-FreeLibrary Percent Alignment Concordantly
Fig. 8. Size insert distribution calculated using Picard Insertion
Size Metrics tool for Illumina TruSeq DNA PCR-Free library1
.
Insert Size
0 200
FR
1000200030004000500060000
400 600 800
Count
4. In summation, using the Beckman Coulter Biomek
FXP
, in conjunction with the Illumina TruSeq DNA
PCR-Free Library Preparation Kit, results in sequence-
ready, amplification-free DNASeq libraries appropriate
for sequencing on all Illumina sequencing platforms.
Deck configuration of the Biomek FXP Dual-Arm Multi-96
and Span 8 Liquid Handler.
ALPs/Devices Required
Part Number Qty. Manufacturer Description
719948 1 Beckman Coulter, Inc. ALP, High-Density, 12-Position, 4 x 3
379448 1 Beckman Coulter, Inc. ALP, Shaking, Orbital, Single-Position
719357 2 Beckman Coulter, Inc. ALP, Standard Single-Position
719361 1 Beckman Coulter, Inc. ALP, Cooling/Heating, Single-Position
A93942 1 Beckman Coulter, Inc. Shaking Peltier ALP
719590 1 Beckman Coulter, Inc. Waste, Span-8, ALP
719356 1 Beckman Coulter, Inc. Disposable Tip Loader ALP
719654 1 Beckman Coulter, Inc. ALP, Tip Wash, 8-Channel
719363 1 Beckman Coulter, Inc. Wash Station including Pump and Tubes
719366 1 Beckman Coulter, Inc. Biomek FX Device Controller
Request a Quote 1 Beckman Coulter, Inc.
(Optional) Biometra T-Robot for On-Deck
Incubations
Conclusion
Illumina TruSeq PCR-Free libraries migrate later in
automated electrophoresis platforms, such as the Agilent
2100 Bioanalyzer, due to the structure of the Illumina
TruSeq adapters. Our results, shown in Figure 3, reflect
this fact and are consistent with similar Agilent 2100
Bioanalyzer data presented in the Illumina TruSeq DNA
PCR-Free protocol. qPCR validation of Illumina TruSeq
DNA PCR-Free libraries created using the Biomek FXP
,
presented in Figure 4, shows that the yield of sequence-
ready libraries was more than double the 2 nM
minimum amount required by the Illumina TruSeq DNA
PCR-Free protocol.
Auxiliary Equipment for QC Testing
Part Number Manufacturer Description
G2940CA Agilent Technology Agilent 2100 Bioanalyzer
5067-4626 Agilent Technology High-Sensitivity DNA Kit
4351405 Life Technologies
7900HT Fast Real-Time PCR System with Fast
96-Well Block Module
KK4824 Kapa Biosystems Library Quantification Kit—Illumina/Universal
SY-410-1003 Illumina MiSeq System
5. Labware Required
Part Number Qty. Manufacturer Description
B01124 1 Beckman Coulter, Inc. Biomek Span-8 P1000 Tips, Pre-Sterile with Barrier
379503 1 Beckman Coulter, Inc. Biomek Span-8 P250 Tips, Pre-Sterile with Barrier
A21586 3 Beckman Coulter, Inc. Biomek P50 Tips, Pre-Sterile with Barrier
717253 1 Beckman Coulter, Inc. Biomek AP96 P250 Tips, Pre-Sterile with Barrier
372790 1 Beckman Coulter, Inc. Quarter Reservoir
534681 1 Beckman Coulter, Inc. Half Reservoir, Nonpyrogenic
372792 1 Beckman Coulter, Inc. Quarter Reservoir, Divided by Width
372795 1 Beckman Coulter, Inc. Frame for Reservoirs
A32782 1 Beckman Coulter, Inc. Agencourt SPRIPlate 96R—Ring Super Magnet Plate
A83054 1 Beckman Coulter, Inc. Blue Heater/Chiller 24-Well Block
AB-1127 5 Thermo Scientific ABgene 96-Well Storage Plate, Square Well, 1.2 mL
16466-042 14 VWR 2 mL SuperClear® Screw Cap Microcentrifuge Tubes—Conical Bottom
HSP-9641 4 Bio-Rad Hard-Shell® Thin-Wall 96-Well Skirted PCR Plates
MSL-2022 1 Bio-Rad Arched Auto-Sealing Lids*
* Optional: For on-deck thermocycling only.
User-Supplied Consumables
Part Number Manufacturer Description
AB00138-01000 American Bioanalytical Ethanol
FC-121-3001 or
FC-121-3002 or
FC-121-3003
Illumina
Illumina TruSeq DNA PCR-Free Sample Prep
LT Set A (24 samples); Illumina TruSeq DNA
PCR-Free Sample Prep LT Set B (24 samples);
or Illumina TruSeq DNA PCR-Free Sample
Prep HT (96 samples)
Software Used in QC Testing
Bowtie 2 (version 0.2) installed on Galaxy Main
(usegalaxy.org)
Picard Insertion Size Metrics tool (version 1.56) installed
on Galaxy Main (usegalaxy.org)